ContributorsPublishersAdvertisers

Ventyx Biosciences sets IPO terms, to be valued at up to $804 million

MarketWatch
MarketWatch
 2021-10-15
Cover picture for the article

Ventyx Biosciences Inc. has set terms for its initial public offering, in which the California-based biopharmaceutical company focused on inflammatory disease treatments looks to raise up to $132.8 million. The company is offering 7.81 million shares in the...

www.marketwatch.com

Comments / 0

Comments / 0